Your Article Summary
See Latest ArticlesNew Data Proves Effectiveness of Medtronic Insertable Cardiac Monitor in Detecting AF, Most Common Heart Rhythm Disorder
Medtronic, 06/24/09
Atrial fibrillation is the most common arrhythmia, affecting an estimated 7 million people worldwide, including 4.5 million in the European Union. Data presented today as a Hot Line session at the EUROPACE 2009 congress on the XPECT clinical trial, sponsored by Medtronic, Inc. , shows that the Medtronic Reveal XT Insertable Cardiac Monitor reliably identifies patients with AF and correctly confirms the absence of AF in patients.
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
Sanofi Pasteur expands study of vaccine against Clostridium difficile into the U.S.
Sanofi-aventis, 12/15/09
Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreichs Ataxia Preclinical Development Program
Repligen, 12/15/09
AstraZeneca and the University of Virginia sign strategic research collaboration to develop novel treatments for cardiovascular disease
AstraZeneca, 12/15/09